Citigroup’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.5M | Buy |
|
|||||
|
2025
Q1 | $3.3M | Buy |
|
|||||
|
2024
Q4 | $2.9M | Sell |
|
|||||
|
2024
Q3 | $3.18M | Sell |
|
|||||
|
2024
Q2 | $3.45M | Buy |
|
|||||
|
2024
Q1 | $3.02M | Buy |
|
|||||
|
2023
Q4 | $2.4M | Sell |
|
|||||
|
2023
Q3 | $3.05M | Buy |
|
|||||
|
2023
Q2 | $2.17M | Sell |
|
|||||
|
2023
Q1 | $3.61M | Buy |
|
|||||
|
2022
Q4 | $2.29M | Buy |
|
|||||
|
2022
Q3 | $132K | Sell |
|
|||||
|
2022
Q2 | $149K | Sell |
|
|||||
|
2022
Q1 | $223K | Sell |
|
|||||
|
2021
Q4 | $328K | Sell |
|
|||||
|
2021
Q3 | $566K | Sell |
|
|||||
|
2021
Q2 | $493K | Buy |
|
|||||
|
2021
Q1 | $173K | Sell |
|
|||||
|
2020
Q4 | $312K | Sell |
|
|||||
|
2020
Q3 | $427K | Sell |
|
|||||
|
2020
Q2 | $479K | Buy |
|
|||||
|
2020
Q1 | $317K | Sell |
|
|||||
|
2019
Q4 | $495K | Buy |
|
|||||
|
2019
Q3 | $116K | Buy |
|
|||||
|
2019
Q2 | $121K | Buy |
|
|||||
|
2019
Q1 | $70K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $9K | Sell |
|
|||||
|
2017
Q4 | $42K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $1K | Sell |
|
|||||
|
2015
Q1 | $1K | Buy |
|